Practice Management
With great excitement—and in full disclosure—I am writing this as the newly elected President of the College of Urgent Care Medicine (CUCM) and Urgent Care College of Physicians (UCCOP). It is truly a pleasure to have been elected during the most recent Urgent Care Conference this past April in Chicago, and I look forward to leading these organizations for the next 2 years. Now I am calling all urgent care clinicians—nurse practitioners (NPs), physician assistants/associates …
Read More
Pediatric Antibiotic Prescribing: In-Person Vs Telemedicine Take Home Point: Telemedicine integrated within primary care was associated with more judicious antibiotic prescribing without increased follow-up visits or inappropriate antibiotic use. Primary care telemedicine may improve access to care while supporting antibiotic stewardship efforts. Citation: Ray K, Wittman S, Kelly M, et al. Primary Care Telemedicine vs In-Person Antibiotic Prescribing for Pediatric Respiratory Tract Infections. JAMA Netw Open. 2026;9(5):e2610062. doi:10.1001/jamanetworkopen.2026.10062. Relevance: Acute respiratory illness (ARI) is a …
Read More
A 28-year-old male with history of left shoulder dislocations presents to urgent care with severe left shoulder pain. He reports an inability to move the arm after injuring his shoulder while taking off his shirt. He reports feeling the shoulder “shift out of place” during the movement. On examination, the patient is in significant discomfort. He is holding the left arm in slight abduction with left shoulder external rotation. His elbow is flexed and his …
Read More
The Food and Drug Administration (FDA) this month approved tebipenem pivoxil for adults with complicated urinary tract infections (cUTIs), including pyelonephritis, in patients who have limited or no alternative oral treatment options. Marketed as Utebzi, it is one of the more significant antibiotic approvals in recent years because it is the first oral carbapenem antibiotic available in the United States, according to manufacturer GSK. Until now, carbapenems (eg, ertapenem, meropenem, and imipenem) have generally required …
Read More
Cases of tetanus in the United States rose from 17 in 2020 to 38 in 2025, according to the latest data from the Centers for Disease Control and Prevention (CDC), prompting public health experts to suggest that Americans might check their vaccine status and consider boosters when appropriate. CDC reported that from 2009–2023 there were 402 reported tetanus cases nationwide—an average of about 27 cases per year with 37 total deaths. However, other signs indicate …
Read More
An AI model developed by researchers at New York-Presbyterian and Columbia University Irving Medical Center has received approval from the Food and Drug Administration for use in detecting structural heart disease through electrocardiograms (ECGs), according to a news release. Known as EchoNext, the deep learning model was trained to detect a broad range of structural abnormalities, as published in Nature: The model analyzes a routine 12-lead ECG and estimates whether a patient is likely to …
Read More
In an analysis of 3.4 million women under age 40, researchers in Japan found a strong association between menstrual-related disorders (ie, endometriosis or dysmenorrhea) and diagnosed sexually transmitted infections (STIs). Among the 257,897 women with these conditions, STI diagnoses were consistently 4.31–5.29 times more common than among women without the disorders, as published in PLOS One. Genital chlamydia infection showed the largest absolute difference, affecting 3.53% of women with menstrual-related disorders compared with 0.67% of …
Read More
If approved, a new seasonal flu shot would become the first commercially available flu vaccine using mRNA technology, according to a news release. Moderna’s seasonal influenza vaccine mRNA-1010 (marketed as mFlusiva) has not yet received final Food and Drug Administration (FDA) approval, but it has reached a major milestone. On June 18, the agency’s vaccine committee voted unanimously that the mRNA vaccine’s benefits outweigh its risks for adults aged 50 years and older, as published …
Read More
The Food and Drug Administration (FDA) has approved the first over-the-counter continuous glucose monitor (CGM) indicated for children aged 2 years and older who do not use insulin, according to an agency news release. The wearable device continuously measures glucose levels and displays readings and trends through a smartphone application, which can be used on a caregiver’s device. Real-time glucose data—measured every 15 minutes—is intended to help children and their parents better understand the effects …
Read More